Introducing Our 250+ Speakers

 

 

Key Speakers

Shinya Yamanaka Director and Professor, Center for iPS Cell Research & Application (CiRA) Kyoto University Center for iPS Cell Research & Application (CiRA) Shinya Yamanaka 
Director and Professor, Center for iPS Cell Research & Application (CiRA) 
Kyoto University

Kathy High President and Head, Research & Development Spark Therapeutics Spark Therapeutics Kathy High 
President and Head, Research & Development 
Spark Therapeutics

Dr James Miskin Chief Technical Officer Oxford BioMedica Oxford BioMedica Dr James Miskin 
Chief Technical Officer 
Oxford BioMedica

Chip Baird CFO Bluebird Bio Bluebird Bio Chip Baird  
CFO  
Bluebird Bio

Doug Danison   
VP Market Access
Value & Evidence Strategy   

Bluebird Bio

Alan Smith Executive Vice President, Technical Operations Bellicum Pharmaceuticals Bellicum Pharmaceuticals Alan Smith 
Executive Vice President, Technical Operations 
Bellicum     Pharmaceuticals

Bob Smith Senior Vice President, Global Gene Therapy Business Pfizer Pfizer Michael Binks  
Senior Vice President, Global Gene Therapy Business 
Pfizer

Dr Joanne Kurtzberg Director Carolinas Cord Blood Bank At Duke Carolinas Cord Blood Bank At Duke Dr Joanne Kurtzberg 
Director 
Carolinas Cord Blood Bank At Duke

Dr Roy Baynes SVP & Head Global Clinical Development, Chief Medical Officer Merck Sharp and Dohme (MSD) Merck Sharp and Dohme (MSD) Dr Roy Baynes 
SVP & Head Global Clinical Development, Chief Medical Officer 
Merck Sharp and Dohme (MSD)

Derek Jantz, Co-founder and CSO, Precision BioSciences Precision BioSciences Derek Jantz 
Co-founder and CSO
Precision BioSciences

 

Stephan Grupp, Director of Translational Research, The Children's Hospital of Philadelphia The Children's Hospital of Philadelphia Stephan Grupp
Director of Translational Research
The Children's Hospital of Philadelphia

Fred Chereau, President and CEO, Logic Biotherapeutics Logic Biotherapeutics Fred Chereau 
President and CEO
Logic Biotherapeutics

Edward Rebar, Senior Vice President And Chief Technology Officer, Sangamo Therapeutics Sangamo Therapeutics Edward Rebar
Senior Vice President And Chief Technology Officer
Sangamo Therapeutics

 
 
 

Mayur Abhaya, Managing Director And Chief Executive Officer, Lifecell Ltd

Mayur Abhaya | Managing Director And Chief Executive Officer | Lifecell Ltd » speaking at Advanced Therapies

Kathrin Adlkofer, Chief Executive Officer, Cellbox Solutions GmbH

Pinar Akcakaya, Senior Research Scientist, AstraZeneca

Pinar Akcakaya | Senior Research Scientist | AstraZeneca » speaking at Advanced Therapies

Luca Alberici, Chief Business Officer, MolMed

Iraj Ali, Chief Executive Officer, Achilles Therapeutics

Iraj Ali | Chief Executive Officer | Achilles Therapeutics » speaking at Advanced Therapies

Evren Alici, Assistant Professor And Group Leader, Haematology, Karolinska Institutet

Omar Aljitawi, Associate Professor, University of Rochester Medical Center

Eric Alton, Professor Of Gene Therapy And Respiratory Medicine, Faculty of Medicine National Heart and Lung Institute Imperial College London

Dorothee Andres, Senior Policy Adviser, Federal Ministry of Health Germany

Dorothee Andres | Senior Policy Adviser | Federal Ministry of Health Germany » speaking at Advanced Therapies

Jane Andrews Ph. D,, Founder & CEO-Cell Bridge Strategies; Consultant, BioBridge Global

Diego Ardigo, R&D Rare Diseases Unit Head, Chiesi Farmaceutici SpA

Stephen Badylak, Deputy Director, Mcgowan Institute For Regenerative Medicine, University of Pittsburgh

Chip Baird, Chief Financial Officer, bluebird bio

David Baram, Chief Executive Officer, Emendo Biotherapeutics

David Baram | Chief Executive Officer | Emendo Biotherapeutics » speaking at Advanced Therapies

Tomasz Baran, Board Member, PBKM/FamiCord Group

Tomasz Baran | Board Member | PBKM/FamiCord Group » speaking at Advanced Therapies

Samantha Barber, CEO, Batten Disease Family Association

Jacqueline Barry, Chief Clinical Officer, Cell and Gene Therapy Catapult

Frank Barry, Scientific Director, Regenerative Medicine Institute

Frank Barry | Scientific Director | Regenerative Medicine Institute » speaking at Advanced Therapies

Shirley Bartido, Director Of Regulatory Affairs, Cellectis SA

Adi Barzel, Senior Lecturer, Tel Aviv University

Dr Roy Baynes, Senior Vice President And Head Global Clinical Development, Chief Medical Officer, Merck Sharp and Dohme (MSD)

Robert Beckman, Managing Partner, The Channel Group, LLC

Robert Beckman | Managing Partner | The Channel Group, LLC » speaking at Advanced Therapies

Tim Bertram, Chief Executive Officer, inRegen

Michael Binks, Vice President, Rare Disease Clinical Research, Pfizer

Michael Binks | Vice President, Rare Disease Clinical Research | Pfizer » speaking at Advanced Therapies

Martin Birchall, Professor Of Laryngology, UCL

Axel Boehnke, Director Market Access (Global Responsibility), PTC Therapeutics

Jaap Boelens, Chief; Stem Cell Transplantation And Cellular Therapies Pediatrics, Memorial Sloan-Kettering Cancer Center

Chris Bond, Director, Future Health Biobank

Chris Bond | Director | Future Health Biobank » speaking at Advanced Therapies

Didier Caizergues, Director Of Regulatory Affairs, Genethon

Susana Cantero Peral, Associate Consultant, Mayo Clinic

Kevin Carrick, Director, Science, Standards And Global Biologics, United States Pharmacopeia

Kevin Carrick | Director, Science, Standards And Global Biologics | United States Pharmacopeia » speaking at Advanced Therapies

Manuel Carrondo, Professor, iBET: Instituto de Biologia Experimental e Tecnológica

Paul S Carter, Cell & Gene Therapy Platform Cmc, GlaxoSmithKline

Paul S Carter | Cell & Gene Therapy Platform Cmc | GlaxoSmithKline » speaking at Advanced Therapies

Rhian Carter, Team Leader of Process Research and Development, Oxford Biomedica

Benoit Champluvier, CMC Senior Advisor,, Icosavax

Benoit Champluvier | CMC Senior Advisor, | Icosavax » speaking at Advanced Therapies

Emma Chan, Senior Scientist, Autolus

Emma Chan | Senior Scientist | Autolus » speaking at Advanced Therapies

Haifeng Chen, Chief Executive Officer, Virovek

Frederic Chereau, Chief Executive Officer, LogicBio Therapeutics

Dr Yen Choo, Chief Executive Officer, Progenitor Therapeutics

Scott Clark, Senior Vice President for Global Strategic Alliances,, EVERSANA

Jean-Philippe Combal, Co-Founder And Chief Executive Officer, Vivet Therapeutics

Joana Correia, Executive Director And Chief Scientific Officer, Exogenus Therapeutics

Elena Costariol, EngD Researcher, UCL

David Courtman, Chief Scientific Officer, Northern Therapeutics Inc

Maria Craig, Professor Of Paediatric Endocrinology, University of Sydney

Armando Cuesta Díaz, Partner, Ilana Capital

Doug Danison, Head of Global Pricing, Reimbursement, and Market Access, bluebird bio

Doug Danison | Head of Global Pricing, Reimbursement, and Market Access | bluebird bio » speaking at Advanced Therapies

Davide Danovi, Director, Hipsci Cell Phenotyping Programme, King's College London

Ruud Das, Senior R&D Scientist Bioreactor Technology, Scinus Cell Expansion

Francesco Dazzi, Professor Of Regenerative And Hematological Medicine, King's College London

Charles De Cidrac, Director Of Health Insurance, AXA

Charles De Cidrac | Director Of Health Insurance | AXA » speaking at Advanced Therapies

Michèle De Guise, Director Of Health Services And Technology Assessment, Inesss

Michèle De Guise | Director Of Health Services And Technology Assessment | Inesss » speaking at Advanced Therapies

Carla Deakin, Programme Director - Commercial And Managed Access, NICE

Carla Deakin | Programme Director - Commercial And Managed Access | NICE » speaking at Advanced Therapies

Simone Dimartino, Lecturer, Institute For Bioengineering, University of Edinburgh

Michael Dombeck, Vice President Of Business Development, Precision Biocciences

Jeff Drew, Chief Scientific Officer, Cells4Life Group LLP

Elliot Dunster, Executive Director, Communications, ABPI

Andreas Eberle, Vice President And Head Of Manufacturing, Codon Ag

Dominik Egger, Research Associate, University of Natural Resources and Life Sciences

Victoria English, Victoria English, Co-Founder And Editor, Evernow Publications

Shirin Enshaeifar, Senior Research Fellow, Machine learning and healthcare at the Department of Electronic and Electronic Engineering, University of Surrey

Debora Esposito, Assistant Professor, N.C. State University

Debora Esposito | Assistant Professor | N.C. State University » speaking at Advanced Therapies

Irina Evseeva, Head Of Specialist Services, Anthony Nolan

Irina Evseeva | Head Of Specialist Services | Anthony Nolan » speaking at Advanced Therapies

Jim Fackler, Associate Professor Of Anesthesiology And Critical Care Medicine, John Hopkins School Of Medicine

Jim Fackler | Associate Professor Of Anesthesiology And Critical Care Medicine | John Hopkins School Of Medicine » speaking at Advanced Therapies

Marco Fadda, ATMP & REGENERATIVE MEDICINE SOLUTIONS SPECIALIST, COMECER GROUP

Dr Suzanne Farid, Biochemical Engineering Professor, University College London

Prof Farzin Farzaneh, Professor Of Molecular Medicine, King's College Hospital NHS Trust

Marcie Finney, Associate Director, Cleveland Cord Blood Center

Mark Flower, Vice President, Business Development and Strategic Partnerships, Be The Match BioTherapies

Mark Flower | Vice President, Business Development and Strategic Partnerships | Be The Match BioTherapies » speaking at Advanced Therapies

Lucy Foley, Director Of Biologics, The Centre For Process Innovation (CPI)

Miguel Forte, Chief Executive Officer, Zelluna Immunotherapy

Lazaros Fotopoulos, R&D Manager, Future Health Biobank

Alberto Sanchez Fueyo, Professor In Hepatology, King's College London

Alberto Sanchez Fueyo | Professor In Hepatology | King's College London » speaking at Advanced Therapies

Michela Gabaldo, Head Of Alliance Management, Fondazione Telethon

Nick Gaddum, Lead Device And Delivery Scientist, Cell and Gene Therapy Catapult

Nick Gaddum | Lead Device And Delivery Scientist | Cell and Gene Therapy Catapult » speaking at Advanced Therapies

Lothar Germeroth, Senior Vice President And Managing Director, Juno Therapeutics GmbH, A Celgene Company

Daniel Gibson, Head Of Innovation And Commercialation, Anthony Nolan

Daniel Gibson | Head Of Innovation And Commercialation | Anthony Nolan » speaking at Advanced Therapies

Janet Glassford, Quality Assessor, MHRA

Francesca Gliubich, London Advanced Therapies Director, London Advanced Therapies

Clive Glover, Senior Global Marketing Manager, Cell And Gene Therapy, Pall

Sandro Gomez, Investigator Cell And Gene Therapy Platform Process Development R&D, GlaxoSmithKline

Roberto Gramignoli, Professor, Karolinska Institute

Lise Marie Grav, Postdoc, Technical University of Denmark

Adam Gridley, President And Chief Executive Officer, Histogenics Corporation

Uta Griesenbach, Professor Of Molecular Medicine, Imperiai College London

Stephan Grupp, Chief, Cellular Therapy And Transplant Section, The Children's Hospital of Philadelphia

Ravindra Gupta, Wellcome Trust Senior Fellow in Clinical Science, UCL Division of Infection and Immunity, UCL

Ravindra Gupta | Wellcome Trust Senior Fellow in Clinical Science, UCL Division of Infection and Immunity | UCL » speaking at Advanced Therapies

Miriam Haak, Business Development Manager, Miltenyi Biotec GmbH

Nassir Habboubi, Chief Medical Officer, Celularity

Sam Hall, Partner, Apple Tree Partners

Sam Hall | Partner | Apple Tree Partners » speaking at Advanced Therapies

Joshua Hare, Director Of Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine

Hansjörg Hauser, Head Of Dept. Of Scientific Strategy, Helmholtz Centre for Infection Research GmbH

Thomas Heathman, Business Leader of Technology Development and Manufacturing Development, Hitachi Chemical Advanced Therapeutics Solutions, LLC

Frank Hecht, Vice President Marketing And Sales, CellGenix GmbH

Dawn Henke, Senior Technical Program Manager, Standards Coordinating Body

Dawn Henke | Senior Technical Program Manager | Standards Coordinating Body » speaking at Advanced Therapies

Diana Hernandez, Anthony Nolan

Katherine High, President And Head, Research And Development, Spark Therapeutics

Echo Hindle-Yang, Founder and CEO, MSQ Ventures

Amy Hines, Senior Manager, Collection Network Management, Be The Match BioTherapies

Amy Hines | Senior Manager, Collection Network Management | Be The Match BioTherapies » speaking at Advanced Therapies

Karen Hodgkin, Chief Operating Officer, Cell Medica Ltd

Edward Hodgkin, Partner, Syncona Partners

Lucy Hoppe, Clinical Effectiveness Manager (Evidence Synthesis) In The Clinical Effectiveness Team, Bupa

Lucy Hoppe | Clinical Effectiveness Manager (Evidence Synthesis) In The Clinical Effectiveness Team | Bupa » speaking at Advanced Therapies

Roger Horton, Anthony Nolan Cell Therapy Centre Operational Manager, Anthony Nolan

Poyi Huang, CEO, Albcura Corporation

Annie Hubert, Director, European Public Policy, Alliance for Regenerative Medicine

Annie Hubert | Director, European Public Policy | Alliance for Regenerative Medicine » speaking at Advanced Therapies

Giorgio Iotti, Head of Program Leadership and Control, Rare Disease Unit, Chiesi Farmaceutici SpA

Dr Moshe Israeli, Medical Director, Rabin Medical Center

Dr Moshe Israeli | Medical Director | Rabin Medical Center » speaking at Advanced Therapies

Zoran Ivanovic, Scientific Director, French Blood Institute, région Nouvelle Aquitaine

Dmitrii Ivolgin, Medical Director, Stem Cells Bank Pokrovski

Agnieszka Janeczek, Founder/COO, Renovos

Derek Jantz, Co-Founder And Chief Scientific Officer, Precision Biosciences

John Johnston, Clinical Assessor, MHRA

Robert Jones, VP, Global Bioservices, Cryoport Inc

Margareth Jorvid, Head Of Regulatory Affairs And QA, Immuniucum AB

Margareth Jorvid | Head Of Regulatory Affairs And QA | Immuniucum AB » speaking at Advanced Therapies

Vaidehi Joshi, Scientist II, Therapeutics,, Organovo

Ohad Karnieli, Chief Executive Officer, Atvio Biotechnology

Ohad Karnieli | Chief Executive Officer | Atvio Biotechnology » speaking at Advanced Therapies

Cornelia Kasper, Professor, Biopharmaceutical Production And Technology, B.O.K.U.

Jasmin Kee, Vice President Manufacturing Operations, Cell Medica Ltd

Hans Keirstead, Chief Executive Officer, AiVita Biomedical

Aisha Khan, Executive Director Of Laboratory Operations, Interdisciplinary Stem Cell Institute

Aisha Khan | Executive Director Of Laboratory Operations | Interdisciplinary Stem Cell Institute » speaking at Advanced Therapies

Yiannis Kiachopoulos, Chief Executive Officer, Co-Founder, Causaly

Sven Kili, Vice President And Head Of Gene Therapy Development, Sven Kili Consulting

Sven Kili | Vice President And Head Of Gene Therapy Development | Sven Kili Consulting » speaking at Advanced Therapies

Gareth King, Manager, Catapult Ventures

Gareth King | Manager | Catapult Ventures » speaking at Advanced Therapies

Takashi Kei Kishimoto, Chief Science Officer, Selecta Biosciences Inc

Nadia Konneh, Conference Manager, Terrapinn

Nadia Konneh | Conference Manager | Terrapinn » speaking at Advanced Therapies

Daniel Kraft, Faculty Chair For Medicine And Neuroscience, Singularity University

Ramakrishnan B Kumar, Senior Scientist, Vironova

Dr Joanne Kurtzberg, Director, Carolinas Cord Blood Bank At Duke

Dr Joanne Kurtzberg | Director | Carolinas Cord Blood Bank At Duke » speaking at Advanced Therapies

Jeffrey L Kutok, Chief Scientific Officer, Infinity Pharmaceuticals, Inc

Jean-Pierre Latere, Chief Operating Officer, Celyad

Jane Lebkowski, President, Regenerative Patch Technologies

Chaim Lebovits, Chief Executive Officer, Brainstorm Cell Therapeutics Inc

Michael Leek, Chief Executive Officer, TC BioPharm

Chris Leonforte, Processing And Qc Manager, Anthony Nolan

Chris Leonforte | Processing And Qc Manager | Anthony Nolan » speaking at Advanced Therapies

Paul Lloyd-Evans, Head Of Clinical Biotechnology Centre, N.H.S. Blood and Transplant

Vanda Lopes, Senior Scientist II, R&D, Irvine Scientific

Douglas Losordo, Chief Medical Officer, Caladrius Biosciences

Douglas Losordo | Chief Medical Officer | Caladrius Biosciences » speaking at Advanced Therapies

Ross Macdonald, Chief Executive Officer, Cynata Therapeutics Ltd

Ross Macdonald | Chief Executive Officer | Cynata Therapeutics Ltd » speaking at Advanced Therapies

Greg MacMichael, SVP of Technical Operations, Axovant Sciences

Greg MacMichael | SVP of Technical Operations | Axovant Sciences » speaking at Advanced Therapies

John Maher, Chief Scientific Officer, Leucid Bio

John Maher | Chief Scientific Officer | Leucid Bio » speaking at Advanced Therapies

Joerg Mahlich, Head Heor, Janssen Pharmaceutical K.K.

Rachel Manley, Head Of Global Outreach, Save the Cord Foundation

Rachel Manley | Head Of Global Outreach | Save the Cord Foundation » speaking at Advanced Therapies

Christopher Mann, Scientific And Regulatory Affairs Manager, Asphalion, S.L.

Christopher Mann | Scientific And Regulatory Affairs Manager | Asphalion, S.L. » speaking at Advanced Therapies

Marcello Maresca, Associate Director, AstraZeneca

Milos Marinkovic, Director,Technology Business Development, BioPact

Dr Irene Martini, Lecturer, University La Sapienza

Dr Irene Martini | Lecturer | University La Sapienza » speaking at Advanced Therapies

Irene Mavroudi, Researcher, Public Cord Blood Bank of Crete

Giuseppe Mazza, Chief Executive And Scientific Officer, Engitix

David Mazzo, Chief Executive Officer, Caladrius Biosciences

Richard Mcfarland, Chief Regulatory Officer, Advanced Regenerative Manufacturing Institute

Richard Mcfarland | Chief Regulatory Officer | Advanced Regenerative Manufacturing Institute » speaking at Advanced Therapies

Ian Mckay, Innovation Lead Advanced Therapies, Innovate UK

Ian Mckay | Innovation Lead Advanced Therapies | Innovate UK » speaking at Advanced Therapies

Nick Medcalf, Innovation Lead - Advanced Therapies, Innovate UK

Nick Medcalf | Innovation Lead - Advanced Therapies | Innovate UK » speaking at Advanced Therapies

Stefano Menegatti, Assistant Professor In Chemical And Biomolecular Engineering, North Carolina State University

Stefano Menegatti | Assistant Professor In Chemical And Biomolecular Engineering | North Carolina State University » speaking at Advanced Therapies

Tobias Menne, Consultant Haematologist,, The Newcastle Upon Tyne Hospitals N.H.S. Foundation Trust

Annamaria Merico, Head Of Technology Transfer, Fondazione Telethon

Annamaria Merico | Head Of Technology Transfer | Fondazione Telethon » speaking at Advanced Therapies

Brian Miller, Chief Executive Officer, Sentien Biotechnology

Joanna Miller, Chief Scientific Officer, Cell Therapy Sciences

Joanna Miller | Chief Scientific Officer | Cell Therapy Sciences » speaking at Advanced Therapies

Dr James Miskin, Chief Technical Officer, Oxford Biomedica

Claudia Mitchell, Claudia Mitchell, SVP, Product and Portfolio Strategy, Astellas Pharma

Jennifer Moody, Senior Director, Research Operations, BlueRock Therapeutics

Neill Moray Mackenzie, Chairman And Board Mamber, Cellular Therapeutics Ltd

Neill Moray Mackenzie | Chairman And Board Mamber | Cellular Therapeutics Ltd » speaking at Advanced Therapies

David Morrow, Program Manager, EATRIS

Linda Moss, Clinical Midwife Advisor, Anthony Nolan

Jo Mountford, Head Of Cellular Therapy Research, Scottish National Blood Transfusion Service

Artin Moussavi, Chief Business Officer, TC BioPharm

Alan Muir, Director And Co-Founder, Seven Hills Venture Partners

Alan Muir | Director And Co-Founder | Seven Hills Venture Partners » speaking at Advanced Therapies

Mary Murphy, Principle Investigator, Remedi National University of Ireland Galway

Mary Murphy | Principle Investigator | Remedi National University of Ireland Galway » speaking at Advanced Therapies

Alex Nancekievill, Chief Business Officer, GE Healthcare

Alex Nancekievill | Chief Business Officer | GE Healthcare » speaking at Advanced Therapies

Gopalan Narayanan, Vice President, Complex Bio, Voisin Consulting Life Sciences (VCLS)

Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (Belgium)

David Nees, Business Development Director, eEnzyme, LLC & Healthgen Biotechnology

Andrew Obenshain, Head Of Europe, Bluebird Bio

Jelena Ochs, Manager Business Unit Life Sciences Engineering, Fraunhofer Institute for Production Technology

Eduardo Olavarria, Bmt Program Director, Consultant Haematologist, Imperial College London

Nneka Onwudiwe, Founder And Chief Executive Officer, Pharmacoeconomics Consultants of America

Dominic O'Reagan, Director And Investor, New Mosaic

Jenny Ousbey, Managing Director, Ovid Consulting

Felicia Pagliuca, Co-Founder And Vice President Cell Biology Research And Development, Semma Therapeutics

Helen Papadaki, Professor Of Haematology, School Of Medicine, University Of Crete, Head Of The Department Of Haematology, Public Cord Blood Bank of Crete

Ioannis Papantoniou, Atmp Bioprocessing Coordinator, KU Leuven

Guy Parkes, Head Of Stem Cell Donation, N.H.S. Blood and Transplant

Detlev Parow, Head Pharmaceutical Department, D.A.K.

Vivienne Parry, Head Of Engagement, Genomics England

Vivienne Parry | Head Of Engagement | Genomics England » speaking at Advanced Therapies

Leonard Pattenden, Head of Biotherapeutics Development & Drug Supply Biotherapeutics Development Unit, Cancer Research UK

David Pauza, Chief Science Officer, American Gene Technologies International Inc.

Amnon Pelz, Chief Executive Officer, Taburit

Amnon Pelz | Chief Executive Officer | Taburit » speaking at Advanced Therapies

Andy Peniket, Consultant, Haematologist And Bone Marrow Transplant Physician, NIHR Oxford Biomedical Research Centre

Andy Peniket | Consultant, Haematologist And Bone Marrow Transplant Physician | NIHR Oxford Biomedical Research Centre » speaking at Advanced Therapies

Adam Perriman, Lecturer, University of Bristol

Glenn F Pierce, CMO, Third Rock Ventures, LLC

Glenn F Pierce | CMO | Third Rock Ventures, LLC » speaking at Advanced Therapies

Elena Piletska, Lecturer in Bioanalytical Chemistry, University of Leicester

Elena Piletska | Lecturer in Bioanalytical Chemistry | University of Leicester » speaking at Advanced Therapies

Govind Pindoria, Director Of Venture Support Unit, Imperial Innovations

Dr Nicolas Pineault, Development Scientist, Canadian Blood Services

Sarah Pitluck, Head, Global Pricing And Reimbursement, Spark Therapeutics

Mateusz Poltorak, Research Scientist, Juno Therapeutics

Mateusz Poltorak | Research Scientist | Juno Therapeutics » speaking at Advanced Therapies

Ian Pope, Global director, Brooks Life Sciences

Carolyn Porter, CBO, Oxstem

Jack Price, Head Of Advanced Therapies, National Institute for Biological Standards and Control

Dr Qasim Rafiq, Associate Professor, Bioprocessing Of Cell And Gene Therapies, University College London

Dr Qasim Rafiq | Associate Professor, Bioprocessing Of Cell And Gene Therapies | University College London » speaking at Advanced Therapies

Kavita Raj, Consultant Haematologist, Guy's And St Thomas' Hospital

Kavita Raj | Consultant Haematologist | Guy's And St Thomas' Hospital » speaking at Advanced Therapies

Nasir Rajpoot, Head, Ai For Cellular Pathology,, University of Warwick

Lior Raviv, Vice President Of Development, Pluristem

Edward Rebar, Senior Vice President And Chief Technology Officer, Sangamo Therapeutics

Antonio Regalado, Senior Editor, M.I.T. Technology Review

Antonio Regalado | Senior Editor | M.I.T. Technology Review » speaking at Advanced Therapies

Ajan Reginald, Chief Executive Officer, Celixir

Albert Ribickas, Bmt/Qc Laboratories Manager, Cell Therapies Facility, Moffitt Cancer Center

Mike Rice, Principal, Cello Health BioConsulting Previously Defined Health

Philip Ridley-Smith, Business Development Director, Cobra Biologics

Martha Rook, SVP of Manufacturing, Sigilon Therapeutics

Martha Rook | SVP of Manufacturing | Sigilon Therapeutics » speaking at Advanced Therapies

Dr Barry Rosen, Senior Principal Scientist And Director, AstraZeneca

Jeff Ross, Chief Executive Officer, Miromatrix

Jeff Ross | Chief Executive Officer | Miromatrix » speaking at Advanced Therapies

Delphine Roulland, Senior Manager Public Affairs, European Confederation of Pharmaceutical Entrepreneurs (Belgium)

Igor Rudychev, Senior Director, Business Insights, AstraZeneca

Igor Rudychev | Senior Director, Business Insights | AstraZeneca » speaking at Advanced Therapies

Peter Saltonstall, Chief Executive Officer, National Organization for Rare Disorders (NORD)

Mark Sawicki, Chief Commercial Officer, Cryoport Inc

Machi Scaradavou, Medical Director Of The National Cord Blood Program, New York Blood Center

Machi Scaradavou | Medical Director Of The National Cord Blood Program | New York Blood Center » speaking at Advanced Therapies

Julia Schaft, Managing Director, BioRN

Katja Schmidt, Head Of Market Access And Public Affairs, Novartis

Katja Schmidt | Head Of Market Access And Public Affairs | Novartis » speaking at Advanced Therapies

Manfred Schmidt, Shareholder And Chief Executive Officer, GeneWerk

Dominic Schmidt, Partner, Syncona Investment Management Ltd

Maria Schöpe, Deputy Head Of Production, Vita34

Maria Schöpe | Deputy Head Of Production | Vita34 » speaking at Advanced Therapies

Elizabeth Schwarzbach, Chief Business Officer, The New York Stem Cell Foundation

Angela Scott, Chief Operating Officer, TC BioPharm

Angela Scott | Chief Operating Officer | TC BioPharm » speaking at Advanced Therapies

Ra Session II, Chief Business Officer, BridgeBio-Gene Therapy

Ra Session II | Chief Business Officer | BridgeBio-Gene Therapy » speaking at Advanced Therapies

Beth Shaz, Chief Medical Officer, New York Blood Center

Jonathan Sheffield, Chief Executive Officer, NIHR Clinical Research Network

Bill Shingleton, Alliances Manager, GE Healthcare

Gerard Short, Senior Vice President, Clinical and Regulatory, Freeline Therapeutics

Alex Sim, CEO, Amsbio

Tamir Singer, Head Of Commercial Development, Specialised Commissioning, NHS England

Alan Smith, Executive Vice President, Technical Operations, Bellicum Pharmaceuticals

Rachel Smith, Senior Clinical Project Manager, The Clinical Trial Company Limited

David Smith, Head of Innovation and Engineering, Hitachi Chemical Advanced Therapeutics Solutions, LLC

Steve Smith, Head Of Rare Diseases And Gene Therapy, Next Phase Recruitment

Steve Smith | Head Of Rare Diseases And Gene Therapy | Next Phase Recruitment » speaking at Advanced Therapies

Owen Smith, Principal, 4Bio Capital

Owen Smith | Principal | 4Bio Capital » speaking at Advanced Therapies

Dr Andrea Spezzi, Chief Medical Officer And Co-Founder, Orchard Therapeutics

Mangala Srinivas, Head Of Multiscale Imaging Lab, Radboud University Medical Centre

Samer Srour, Assistant Professor of Medicine, MD Anderson Cancer Center

Dr Glyn Stacey, Executive Director, International Stem Cell Banking Initiative

Sanja Stifter, Professor, Department Of Pathology, Faculty Of Medicine, University of Rijeka

Warachaya Sutheesophon, Medical Director, THAI StemLife Co.,Ltd.

Mathias Svahn, Chief Executive Officer, Nextcell Pharma

Suparna Taneja-Bageshwar, Principal Scientist and AD Group Leader, Fujifilm Diosynth Biotechnologies

Suparna Taneja-Bageshwar | Principal Scientist and AD Group Leader | Fujifilm Diosynth Biotechnologies » speaking at Advanced Therapies

Stefanos Theoharis, Senior Vice President Of Corporate Development And Partnering, Cell Medica Ltd

Stefanos Theoharis | Senior Vice President Of Corporate Development And Partnering | Cell Medica Ltd » speaking at Advanced Therapies

Robert Thomas, Professor in Manufacturing for Cell and Gene Therapies; EPSRC Early Career Fellow, Loughborough University

Vaughn Thomas, Bioprocess Consultant RAEng Visiting Professor at UCL, Tillingbourne Consulting

Dr Frédéric Triebel, Chief Scientific Officer And Medical Officer, Immutep Ltd

Sarah Tsurkan, Cell Biologist, TissueGUARD GmbH

Marc Turner, Medical Director, Scottish National Blood Transfusion Service

Marc Turner | Medical Director | Scottish National Blood Transfusion Service » speaking at Advanced Therapies

Marcos Valadares, Co-Founder, Pluricell

Dr Giuliana Vallanti, Development and Quality Control Director, Molmed SpA

Alain Vertes, Vice President, Alliance Management, Mesoblast Inc

Alain Vertes | Vice President, Alliance Management | Mesoblast Inc » speaking at Advanced Therapies

Rogerio Vivaldi, Chief Executive Officer, Sigilon Therapeutics

Rogerio Vivaldi | Chief Executive Officer | Sigilon Therapeutics » speaking at Advanced Therapies

Dr Ivan Wall, Reader In Department Of Biochemical Engineering, Aston University

Neil Watson, Director of Northern Alliance ATTC, Northern Alliance Advanced Therapies Treatment Centre

Bodil Willumsen, Supplier Relationship Manager, External Supply Operations, Cell And Gene Therapy, Novartis

Bodil Willumsen | Supplier Relationship Manager, External Supply Operations, Cell And Gene Therapy | Novartis » speaking at Advanced Therapies

Michal Wlodarski, Principal, Cambridge Innovation Consulting

David Johannes Wurm, Project Assistant Of Biochemical Engineering, Vienne University of Technology

David Johannes Wurm | Project Assistant Of Biochemical Engineering | Vienne University of Technology » speaking at Advanced Therapies

Shinya Yamanaka, Director And Professor, Center For Ips Cell Research And Application (Cira), Kyoto University

Seppo Yla-Herttuala, Academy Professor, University of Eastern Finland

Seppo Yla-Herttuala | Academy Professor | University of Eastern Finland » speaking at Advanced Therapies

Stefano Zancan, Head Clinical Development And Operations, Fondazione Telethon

 

The World Advanced Therapies and Regenerative Medicine Congress and Exhibition is an international conference and exhibition featuring the latest in advanced therapies, bioengineering and surrounding technology. To attend the conference which features global leaders in the biopharma and regenerative medicine industries, there is a registration fee. The exhibition is free to visit.

Register your pass here.